Header graphic for print
Focus on Regulation

Tag Archives: Pricing

UK Government Given Additional Powers to Control NHS Medicine Prices

The new Health Service Medical Supplies (Costs) Act 2017 came into force on 27 April 2017, giving the Department of Health greater powers to control the cost of medicines supplied to the National Health Service (NHS). The cost of branded medicines supplied to the NHS is regulated through two mechanisms – the Pharmaceutical Price Regulation

Scottish government to reform approval process for new end-of-life and orphan medicines

The Scottish government has announced plans to implement the 28 recommendations proposed in an independent review of access to new end-of-life, orphan and ultra-orphan medicines by patients in Scotland, published in a report on 14 December 2016. The recommendations aim to further improve the process by which these types of medicines, in particular ultra-orphan products,

DOJ and FTC to Shine Spotlight on Analysis of Conditional Pricing Practices Under the Antitrust Laws

The DOJ and FTC have announced a joint one-day workshop on June 23, 2014, in Washington, DC, and are requesting comments by August 22, 2014, on the topic of competition issues relating to conditional pricing practices among firms in a supply chain.  Conditional pricing practices include loyalty or bundled pricing and other arrangements where “prices